Success Metrics

Clinical Success Rate

100.0%

Based on 5 completed trials

Completion Rate

100%(5/5)

Active Trials

1(17%)

Results Posted

0%(0 trials)

Phase Distribution

Ph early_phase_1

17%

Ph not_applicable

83%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution6 total trials

Early Phase 1First-in-human

1(16.7%)

N/ANon-phased studies

5(83.3%)

Highest Phase Reached

Early Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(5)

Detailed Status

Completed5

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Early Phase 1

Trials by Phase

Early Phase 11 (16.7%)

N/A5 (83.3%)

Trials by Status

recruiting117%

completed583%

Recent Activity

1 active trials

Showing 5 of 6

completednot_applicable

Clinical Trials (6)

Showing 6 of 6 trials

NCT07199660Not Applicable

Reactions to Social Media Warning Labels Among Teens and Young Adults

Completed

NCT06787937Not Applicable

Communicating About Nicotine Reduction in Cigarettes

Recruiting

NCT04740008Early Phase 1

Impact of Low Nicotine Cigarette Messaging on Perceptions and Cigarette Choices

Completed

NCT04460703Not Applicable

COVID-19 Vaccine Messaging, Part 1

Completed

NCT03002324Not Applicable

Tailoring of Vaccine-Focused Messages: Disease Salience

Completed

NCT02851459Not Applicable

Tailoring of Vaccine-Focused Messages: Moral Foundations

Completed

All 6 trials loaded

Drug Details

Intervention Type: BEHAVIORAL
Total Trials: 6